期刊文献+

重组人内皮抑素对肺癌细胞H-52黏附和侵袭力的影响

下载PDF
导出
摘要 目的:观察重组人内皮抑素对肺癌细胞H-52增殖和凋亡的影响。方法:在培养液中加入梯度浓度的重组人内皮抑素(0.1、0.5、1.0,5.0、10.0、20.0mg/L)分别作用24、48、72 h,采用噻唑蓝(MTT)比色法检测细胞黏附性,以Transwell方法检测癌细胞侵袭能力。结果:内皮抑素对H-52细胞的增殖有抑制作用。其中,作用48 h的抑制率分别为13.46%、15.38%、20.82%、24.71%、30.12%和37.44%,呈剂量依赖关系。给药后24 h和48 h,内皮抑素组细胞G/G期比例增高,而s期细胞比例降低(P<0.05)。72 h两组差异无统计学意义(P>0.05)。24 h和48 h的凋亡率分别为(1.430±0.145)%和(1.760±0.054)%,均高于对照组(0.670±0.181)%和(1.260±0.138)%(P<0.05)。透射电子显微镜下,内皮抑素组细胞微绒毛减少,染色质厚薄不均,位于核膜下。结论:重组内皮抑素可以在体外直接抑制肺癌细胞的增殖,诱导凋亡,影响细胞骨架等结构。
作者 陈东 张风林
机构地区 唐山市人民医院
出处 《贵阳中医学院学报》 2013年第6期303-305,共3页 Journal of Guiyang University of Chinese Medicine
  • 相关文献

参考文献16

  • 1O' Reilly MS,Boehm T,Shing Y. Endostatin:an endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,growth[J].{H}CELL,1997.277-285.
  • 2Folkman J. Antiangi0genesis in cancer therapy-endostatin and its mechanisms of action[J].{H}Experimental Cell Research,2006.594-607.
  • 3Sauter BV,Marinet O,Zhang wj. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases[J].{H}Proceedings of the National Academy of Sciences(USA),2000.4802-4807.
  • 4李中信,贾漪涛,刘敏,陈书艾,王立莎,张雷.重组人内皮抑素对裸鼠结肠癌移植瘤淋巴管生成及淋巴结转移的抑制作用[J].中华实验外科杂志,2010(4):463-464. 被引量:2
  • 5Kim YM,Jang jw,Lee OH. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity ofmatrix metalloproteinase[J].{H}CANCER RESEARCH,2000.1503-1506.
  • 6Nyberg P,Heikkila P,Sorsa T. Endostatin inhibits human tonguecarcinoma cell invasion an d intravasation an d blocks the activationofmatrix metalloptotease-2,-9,and-13[J].{H}Journal of Biological Chemistry,2003.22404-22411.
  • 7侯树坤,杜志军,王晓峰,闫征,顾永鹏,叶海云.内皮抑素抑制膀胱癌皮下移植瘤生长及其机制的初步探讨[J].中华泌尿外科杂志,2002,23(10):590-593. 被引量:23
  • 8Folkman J. Antiangi. genesis:new concept for therapy of solid tumors[J].{H}ANNALS OF SURGERY,1972.409-416.
  • 9Hanai J,Dhanabal M,Karmanchi SA. Endostatin causes G1 atrest of endothelial cells through inhibition of cyclin D1[J].{H}Journal of Biological Chemistry,2002.16464-16469.
  • 10Sathomsumetee S,Rich JN. Antiangiogenic therapy in malignant glioma:promise and challenge[J].{H}Current Pharmaceutical Design,2007.3545-3558.

二级参考文献21

  • 1范恩学,孙海侠,丁道亮,王志民.血管抑素和内皮抑素在小鼠开窗肿瘤模型的应用[J].中华实验外科杂志,2004,21(7):872-872. 被引量:5
  • 2王深明,朱彩霞,黎志勋,王劲松,林颖.乳腺癌血行转移与血管生成相关因子相关性研究[J].中华实验外科杂志,2005,22(5):524-526. 被引量:17
  • 3胡鸢,段小军,杨柳.缺氧诱导因子-1α基因转染人间充质干细胞的体内促血管生成作用[J].中华实验外科杂志,2006,23(8):993-996. 被引量:13
  • 4Moeller Moeller BJ,Cao Y,Li CY,et al.Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors:Role of reoxygenation,free radicals,and stress granules.Cancer Cell,2004,5:429-441.
  • 5Robert S,Kerbel T.Antiangiogenic Therapy:A universal chemosensitization strategy for cancer? Science,2006,26:1171-1174.
  • 6Alitalo g,Tammela T,Petrova TV,et al.Lymphangiogenesis in development and human disease.Nature,2005,438:946-953.
  • 7Thiele W,Sleeman JP.Tumor-induced lymphangiogenesis:a target for cancer therapy? J Biotechnol,2006,124:224-241.
  • 8Brideau G,Makinen MJ,Elamaa H,et al.Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.Cancer Res,2007,67:11528-11535.
  • 9Ling Y,Yang Y,Lu N,et al.Endostar,a novel recombinant human endostatin,exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.Biochem Biophys Res,2007,361:79-84.
  • 10Boehm T,Folkman J,Browder T,et al.Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[].Nature.1999

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部